Concepedia

Michele Fernandes

MF

4

Publications

495

Citations

4

H-Index

1981

Active since

Affiliations

Loxo Oncology at Lilly (United States)(Current)

Michele Fernandes is an author at Loxo Oncology at Lilly (United States) specializing in molecular pharmacology, drug discovery, and cell signaling.

Top concepts

Publications per year

1981–2015

4

Publications

4

An Oncogenic <i>NTRK</i> Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Robert C. Doebele, Lara E. Davis, Aria Vaishnavi et al. · Cancer Discovery · 2015 · 385 citations · Full text

Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study

Huw Ellis, Steven Cowman, Michele Fernandes et al. · European Respiratory Journal · 2015 · 83 citations

3‐Hydroxy‐3‐methylglutaric aciduria combined with 3‐methylglutaconic aciduria: A new case

P. Divry, Marie-Odile Rolland, J. Teyssier et al. · Journal of Inherited Metabolic Disease · 1981 · 17 citations

A first-in-human study of LOXO-101, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family.

Howard A. Burris, Marcia S. Brose, Alice T. Shaw et al. · Journal of Clinical Oncology · 2015 · 10 citations

, , +23

Rows per page

1–4 of 4